{
    "2018-03-27": [
        [
            {
                "time": "2018-03-27",
                "original_text": "明日最具投资机会六大牛股一览（2018年3月27日）",
                "features": {
                    "keywords": [
                        "投资机会",
                        "牛股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "中财独家:百股涨停再现 A股市场仍有可为？机构预测",
                "features": {
                    "keywords": [
                        "涨停",
                        "A股",
                        "机构预测"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "[推荐评级]医药行业周报：三把“火”有望催化医药“大年”",
                "features": {
                    "keywords": [
                        "推荐评级",
                        "医药行业",
                        "周报",
                        "催化"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "[审慎增持评级]益丰药房(603939)年报点评：业绩稳健增长 持续外延布局",
                "features": {
                    "keywords": [
                        "审慎增持",
                        "益丰药房",
                        "年报",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "[买入评级]益丰药房(603939)年报点评：快速扩张规模+盈利能力提升 业绩高速增长",
                "features": {
                    "keywords": [
                        "买入评级",
                        "益丰药房",
                        "年报",
                        "扩张",
                        "盈利能力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "国家卫生健康委员会正式挂牌 医药创新时代首选重配医药",
                "features": {
                    "keywords": [
                        "国家卫生健康委员会",
                        "医药创新",
                        "重配医药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "[领先大市-B评级]医药行业周度报告：深化改革再发文 推行高值耗材“两票制”",
                "features": {
                    "keywords": [
                        "领先大市",
                        "医药行业",
                        "深化改革",
                        "两票制"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "益丰药房2017年营收48亿 深耕中南华东市场",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "营收",
                        "中南华东市场"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-27",
                "original_text": "【医药丨周小刚】益丰药房(603939)：扣非利润实现42%增长，精细化运营龙头优势凸显",
                "features": {
                    "keywords": [
                        "扣非利润",
                        "增长",
                        "精细化运营",
                        "龙头优势"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}